Targets and targeting of immunometabolism in chronic PM2.5 exposure
慢性 PM2.5 暴露中免疫代谢的目标和靶向
基本信息
- 批准号:10563199
- 负责人:
- 金额:$ 40.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-07 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAccelerationAcute DiseaseAir PollutantsAir PollutionAnimalsAnti-Inflammatory AgentsAntioxidantsArterial Fatty StreakArteriesAtherosclerosisBone Marrow TransplantationCardiometabolic DiseaseCardiovascular DiseasesCellsChIP-seqCholesterolChronicChronic DiseaseDataDietDietary InterventionDisease ProgressionDonor personEnvironmentEnvironmental Risk FactorEnzymesErythroidEtiologyExposure toFatty acid glycerol estersFingerprintFlow CytometryFluorescenceGATA1 geneGenesHealthHumanImmuneImpairmentIn VitroInflammationInflammatoryIngestionInhalationInjectionsInterventionLaboratoriesLesionLinkLip structureLipidsMacrophageMapsMass Spectrum AnalysisMediatingMeta-AnalysisMetabolicMetabolic DiseasesModelingMolecularMorbidity - disease rateMusMyelogenousMyeloid CellsNon-Insulin-Dependent Diabetes MellitusNuclearPTPRC geneParticulateParticulate MatterPathway interactionsPhenotypePlasmaPlayPopulationPredispositionPublic HealthRegimenResolutionRiskRisk FactorsRoleSamplingSeriesSerumShapesSortingStressTestingTherapeutic InterventionTimeUp-RegulationWorkair filterattributable mortalitycardiometabolic riskcardiovascular effectscardiovascular risk factorcytokinedietarydietary manipulationepigenomicsfine particlesin vivoirradiationmetabolomicsmetermonocytemortalitynovelnuclear factor-erythroid 2oxidationperipheral bloodpharmacologicresponsesystematic reviewtranscriptome sequencingtranscriptomics
项目摘要
Project Summary
PM2.5 is a leading global risk factor for morbidity and mortality and is the leading environmental factor
implicated in cardiovascular disease. Recent data suggest that PM2.5 and/or traffic-related air pollutants may
play a role in chronic diseases such as Type 2 diabetes mellitus, that may in turn confer susceptibility to
cardiovascular disease and has been the topic of multiple systematic reviews and meta-analysis by us and
others. In a series of studies in animals and humans, we have provided convincing evidence linking PM2.5 to
pathways playing an etiologic role in cardiometabolic disease. Our findings and reviews have fundamentally
shaped the understanding of the effects of PM2.5 and its association with increased risk of cardiometabolic
disease. In particular, our group has demonstrated pro-atherogenic effects of chronic PM2.5 exposure, through
ROS and inflammation dependent pathways. Although our understanding of pathways contributing to
progression of disease has been dramatically enhanced, the mechanisms involved in the resolution of
inflammation and an understanding of how dysregulation of resolution pathways contributes to disease
progression has been limited. Identification of these mechanisms could pave the way for new opportunities to
target non only air pollution mediated cardiovascular risk but other pervasive health risks. Through the
implementation of three specific aims this proposal seeks to: 1) characterize air pollution-induced changes in
inflammation resolution pathways; 2) determine to what extent these pathways overlap with dietary
manipulation; 3) identify potential intervention strategies to promote upregulation of conserved resolution
pathways in response to air pollution-induced inflammation.
项目概要
PM2.5 是全球发病率和死亡率的主要风险因素,也是主要的环境因素
与心血管疾病有关。最近的数据表明,PM2.5 和/或与交通相关的空气污染物可能会
在 2 型糖尿病等慢性疾病中发挥作用,进而可能导致对以下疾病的易感性
心血管疾病,已成为我们和美国多个系统评价和荟萃分析的主题
其他的。在对动物和人类进行的一系列研究中,我们提供了令人信服的证据,证明 PM2.5 与
在心脏代谢疾病中发挥病因作用的途径。我们的调查结果和评论从根本上
形成了对 PM2.5 影响及其与心脏代谢风险增加之间关系的理解
疾病。特别是,我们的小组通过以下方法证明了长期暴露于 PM2.5 的促动脉粥样硬化作用:
ROS 和炎症依赖性途径。尽管我们对途径的理解有助于
疾病的进展已显着增强,解决问题的机制
炎症以及对消退途径失调如何导致疾病的理解
进展受到限制。确定这些机制可以为新的机会铺平道路
不仅针对空气污染介导的心血管风险,还针对其他普遍的健康风险。通过
该提案旨在实现三个具体目标:1)描述空气污染引起的变化的特征
炎症消退途径; 2)确定这些途径与饮食重叠的程度
操纵; 3)确定潜在的干预策略以促进保守分辨率的上调
应对空气污染引起的炎症的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrei Maiseyeu其他文献
Andrei Maiseyeu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrei Maiseyeu', 18)}}的其他基金
Targets and targeting of immunometabolism in chronic PM2.5 exposure
慢性 PM2.5 暴露中免疫代谢的目标和靶向
- 批准号:
10349277 - 财政年份:2022
- 资助金额:
$ 40.25万 - 项目类别:
Non-racemic metabolic biomaterials for HFpEF
用于 HFpEF 的非外消旋代谢生物材料
- 批准号:
10295348 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
Non-racemic metabolic biomaterials for HFpEF
用于 HFpEF 的非外消旋代谢生物材料
- 批准号:
10677638 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
Non-racemic metabolic biomaterials for HFpEF
用于 HFpEF 的非外消旋代谢生物材料
- 批准号:
10677638 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
Non-racemic metabolic biomaterials for HFpEF
用于 HFpEF 的非外消旋代谢生物材料
- 批准号:
10470026 - 财政年份:2021
- 资助金额:
$ 40.25万 - 项目类别:
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles
使用纳米颗粒探索 GLP-1 的心血管作用
- 批准号:
9914122 - 财政年份:2016
- 资助金额:
$ 40.25万 - 项目类别:
相似国自然基金
基于增广拉格朗日函数的加速分裂算法及其应用研究
- 批准号:12371300
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
肠菌源性丁酸上调IL-22促进肠干细胞增殖加速放射性肠损伤修复的机制研究
- 批准号:82304065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肌红蛋白构象及其氧化还原体系探究tt-DDE加速生鲜牛肉肉色劣变的分子机制
- 批准号:32372384
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于联邦学习自动超参调整的数据流通赋能加速研究
- 批准号:62302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
M2 TAMs分泌的OGT通过促进糖酵解过程加速肝细胞癌恶性生物学行为的机制研究
- 批准号:82360529
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Molecular Mechanisms of TOX-mediated Programming of CD8 T Cell Exhaustion
TOX 介导的 CD8 T 细胞耗竭编程的分子机制
- 批准号:
10606385 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Functionally guided adult whole brain cell atlas in human and NHP
人类和 NHP 的功能引导成人全脑细胞图谱
- 批准号:
10687245 - 财政年份:2022
- 资助金额:
$ 40.25万 - 项目类别:
Novel molecular mechanisms of vascular smooth muscle cell-mediated large and small artery calcification
血管平滑肌细胞介导大小动脉钙化的新分子机制
- 批准号:
10670415 - 财政年份:2022
- 资助金额:
$ 40.25万 - 项目类别:
Impact of prenatal inflammation on developing human brain
产前炎症对人类大脑发育的影响
- 批准号:
10705556 - 财政年份:2022
- 资助金额:
$ 40.25万 - 项目类别:
Characterization of human DRG at the single cell level via integrated transcriptomics and spatial proteomics
通过整合转录组学和空间蛋白质组学在单细胞水平表征人类 DRG
- 批准号:
10707415 - 财政年份:2022
- 资助金额:
$ 40.25万 - 项目类别: